<SEC-DOCUMENT>0001558370-22-019046.txt : 20221230
<SEC-HEADER>0001558370-22-019046.hdr.sgml : 20221230
<ACCEPTANCE-DATETIME>20221230163019
ACCESSION NUMBER:		0001558370-22-019046
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20221228
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221230
DATE AS OF CHANGE:		20221230

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AYTU BIOPHARMA, INC
		CENTRAL INDEX KEY:			0001385818
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				470883144
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38247
		FILM NUMBER:		221502290

	BUSINESS ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		(720) 437-6580

	MAIL ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC.
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rosewind CORP
		DATE OF NAME CHANGE:	20070110
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>aytu-20221228x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.1.0.3 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 12/28/2022 6:05:21 PM -->
      <!-- iXBRL Library version: 1.0.8263.24741 -->
      <!-- iXBRL Service Job ID: 038c4458-c573-4218-b5ff-cbc666d4ae79 -->

  <html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:aytu="http://www.aytubio.com/20221228" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:EntityCentralIndexKey" id="Tc_mfdosfUR8U2uarKhlWZWXw_1_1">0001385818</ix:nonNumeric><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:AmendmentFlag" id="Tc_TreCait6okyxYSFGFVbzBQ_2_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="aytu-20221228.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001385818</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-28</xbrli:startDate><xbrli:endDate>2022-12-28</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt 0pt 0pt 7.2pt;"><span style="font-size:1pt;font-weight:bold;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_b77c51e7_41c2_4691_8c6e_779bd9f29e5d"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><span style="font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:14pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:14pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Washington, D.C. 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:DocumentType" id="Narr_WfX4f9f4S0eA287wsXNRsw"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-size:14pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Date of Report (Date of earliest event reported):</b><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_mj9538zcM0CeOD97k8NWgg"><b style="font-weight:bold;"> December 28, 2022</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:EntityRegistrantName" id="Narr_Vmqtgr0240yMAGAq42lfBw"><b style="font-weight:bold;">AYTU BIOPHARMA,&#160;INC.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Exact name of registrant as specified in its charter)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_bc388308_3872_4b3b_a834_1bde8e559995"></a><a id="Tc_SMdaLfH-FkasyxHGTfFPdA_2_0"></a><a id="Tc_aq51vhuSwkKxzOvTwLzuUQ_2_2"></a><a id="Tc_C5ANjn5Wt0-U1sx7rFS8PA_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:32.05%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:middle;width:32.06%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:top;width:1.99%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:middle;width:32.06%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:32.05%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_4tcPL1VfqUSg2ULlPruGFg_1_0"><b style="font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:32.06%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:EntityFileNumber" id="Tc_t8fG7H_KPkGuD6N0ufcR6Q_1_2"><b style="font-weight:bold;">001-38247</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:1.99%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:32.06%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:EntityTaxIdentificationNumber" id="Tc_w-6vKU_cTEqiNvxthLbOPA_1_4"><b style="font-weight:bold;">47-0883144</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:32.05%;border-top:1.0pt solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(State or other jurisdiction of incorporation)</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.06%;border-top:1.0pt solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Commission File Number)</p></td><td style="vertical-align:top;width:1.99%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.06%;border-top:1.0pt solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(IRS Employer Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:EntityAddressAddressLine1" id="Narr_iVKpQL_ztU68PqGXiJ-QeA"><b style="font-weight:bold;">373 Inverness Parkway</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:EntityAddressAddressLine2" id="Narr_NPbG2Q0WnUeWYd4Y-1tiOA"><b style="font-weight:bold;">Suite&#160;206</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:EntityAddressCityOrTown" id="Narr_zDmCcVcm1UyDa6g56bcIyg"><b style="font-weight:bold;">Englewood</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:EntityAddressStateOrProvince" id="Narr_kXiM1He5o0qcWWIc4jNtbA"><b style="font-weight:bold;">CO</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:EntityAddressPostalZipCode" id="Narr_KnqSyI0-oUSFz42WMospWg"><b style="font-weight:bold;">80112</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">(Address of principal executive offices, including Zip Code)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Registrant&#8217;s telephone number, including area code: (</b><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:CityAreaCode" id="Narr_mnnBfTtGhka1n40-dLTstg"><b style="font-weight:bold;">720</b></ix:nonNumeric><b style="font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:LocalPhoneNumber" id="Narr_-2c1kTiFXkGnDMD3t6U5lA"><b style="font-weight:bold;">437-6580</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">N/A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">(Former name or former address, if changed since last report)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18.25pt;"><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_DmJQBTI5JkWUHe2kJ_1KDQ"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18.25pt;"><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_dQdd-xm6R0mFv9XgAFuUnA"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18.25pt;"><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_ndfAp2rsXkqGrDijljorNw"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:18.25pt;"><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_7VHnKnIr6Uudk6XYpo7H1g"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Securities registered pursuant to Section&#160;12(b) of the Act:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_810a9833_6b78_460d_b0c4_ce6f37bb1d34"></a><a id="Tc_nV3TY6EyD0edLxeCqWvW7w_1_0"></a><a id="Tc_BCNQNp0hW0-HCi_Hwmg-DA_1_2"></a><a id="Tc_OWDIQA3Pl0KaRUBFYFYNwA_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:40.38%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:1.54%;margin:0pt;padding:0.25pt 0pt 0.4pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:17.78%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:1.78%;margin:0pt;padding:0.25pt 0pt 0.4pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:38.5%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:40.38%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:top;width:1.54%;margin:0pt;padding:0.25pt 0pt 0.4pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:17.78%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading Symbol(s)</b></p></td><td style="vertical-align:top;width:1.78%;margin:0pt;padding:0.25pt 0pt 0.4pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:38.5%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name of each exchange on which registered</b></p></td></tr><tr><td style="vertical-align:top;width:40.38%;background:#cceeff;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:Security12bTitle" id="Tc_bWOA3VTT_0SYpyRUnljFjQ_2_0"><b style="font-weight:bold;">Common Stock, par value $0.0001 per share</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:1.54%;background:#cceeff;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:17.78%;background:#cceeff;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" name="dei:TradingSymbol" id="Tc_MnDKhzG0w0-VyZC0CpLtlQ_2_2"><b style="font-weight:bold;">AYTU</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:1.78%;background:#cceeff;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:38.5%;background:#cceeff;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_KDiiNDTOw0OIx2bINSNZVw_2_4"><b style="font-weight:bold;">The NASDAQ Stock Market LLC</b></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 8pt 7.2pt;">Emerging growth company <ix:nonNumeric contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_eiUKS2yqsUSn-X_I07LZBQ"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="display:none;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_a9fccc89_c840_47b9_8899_6f3a5f5b9892"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Item 8.01 Other Events.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">As previously reported, a putative class action was filed on February 9, 2022 in the Delaware Chancery Court (the &#8220;Court&#8221;) by Rafal Aponowicz derivatively and on behalf of all Aytu stockholders, challenging the grant in 2021 of certain stock option awards to directors and officers (the &#8220;2021 Grants&#8221;). The stockholder contended that those awards were in amounts exceeding the shares available under the Company&#8217;s 2015 equity incentive plan and that the directors therefore breached their fiduciary duties and breached a purported contract between them and stockholders. The Complaint sought rescission of the awards, unspecified damages to stockholders as a result of the awards, and attorneys&#8217; fees. A second such action was filed by Paul John M. Paguia on March 7, 2022; Mr. Paguia asserted the same claims and seeks the same relief. The parties have agreed to settle these matters, subject to approval by the Court.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">On December 19, 2022, the Company entered into a Stipulation of Compromise and Settlement (the &#8220;Stipulation&#8221;) with respect to these actions. Pursuant to the terms of the Stipulation, the Company has agreed, among other things, to (i) cancel 25% of the aggregate 2021 Grants; (ii) add two new directors who meet the NASDAQ independence standards within six months of the date of final Court Approval (one of whom has already been appointed); (iii) designate a lead independent director; (iv) adopt a new equity compensation plan and seek approval of the plan at the Company&#8217;s next annual meeting with a share reserve not ever to exceed 15% of the Company&#8217;s then outstanding shares; (v) not issue further awards to the named defendants under the Company&#8217;s prior incentive plan; and (vi) limit aggregate non-employee director compensation to $175,000 through 2024. The Stipulation also provides for a release of claims related to the allegations with no admission of wrongdoing. As part of the Stipulation, the Company has agreed to pay an award of attorneys&#8217; fees and expenses to plaintiffs&#8217; counsel up to $425,000. As required by the Court, a copy of the Notice of Pendency of Settlement of Action (the &#8220;Notice&#8221;) is included as Exhibit 99.1 to this Current Report on Form 8-K.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_03b4a623_38a2_4428_92db_10aa44f5881c"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Item 9.01. Financial Statements and Exhibits.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">(d) Exhibits</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b style="font-weight:bold;">Item</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:45pt;text-indent:-45pt;margin:0pt 0pt 0pt 36pt;">99.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="aytu-20221228xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Notice of Pendency of Settlement of Action, approved in connection with a scheduling order dated December 28, 2022.</span></a></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">104 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Cover Page Interactive Data File (formatted as inline XBRL)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_c3f71054_f7f5_48a6_92c2_1e41729054b2"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">SIGNATURES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:53.78%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:3.1%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;white-space:nowrap;width:43.11%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:53.78%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:top;width:46.21%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">AYTU BIOPHARMA,&#160;INC.</p></td></tr><tr><td style="vertical-align:top;width:53.78%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:top;width:46.21%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:top;width:53.78%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:top;width:46.21%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:top;width:53.78%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: December 30, 2022</p></td><td style="vertical-align:top;width:3.1%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By: </p></td><td style="vertical-align:top;white-space:nowrap;width:43.11%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/&#160;Mark Oki</p></td></tr><tr><td style="vertical-align:top;width:53.78%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:3.1%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:43.11%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Mark Oki</p></td></tr><tr><td style="vertical-align:top;width:53.78%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:3.1%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:43.11%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>aytu-20221228xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 12/28/2022 06:05:18 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Exhibit 99.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE</p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 7.2pt 0pt 72pt;"><font style="margin-bottom:12pt;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 7.2pt 12pt 36pt;"><font style="margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt 7.2pt 12pt 0pt;"><font style="margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 7.2pt 12pt 72pt;"><font style="margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 7.2pt 12pt 36pt;">nd</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 7.2pt 12pt 0pt;"><font style="margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 7.2pt 12pt 72pt;"><font style="margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:6pt 7.2pt 12pt 0pt;"><font style="text-transform:uppercase;">RAFAL APONOWICZ, </font>derivatively on behalf of <font style="text-transform:uppercase;">Aytu Biopharma, Inc. </font>and individually on behalf of himself and all other similarly situated stockholders of <font style="text-transform:uppercase;">Aytu Biopharma, Inc.</font>,</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 7.2pt 0pt 72pt;">Plaintiff,</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 7.2pt 12pt 36pt;">v.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt 7.2pt 12pt 0pt;">GARY CANTRELL, JOSHUA DISBROW, CARL DOCKERY, JOHN DONOFRIO, JR., AND MICHAEL MACALUSO,</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 7.2pt 12pt 72pt;">Defendants,</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 7.2pt 12pt 36pt;">and</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 7.2pt 12pt 0pt;">AYTU BIOPHARMA, INC.,</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 7.2pt 12pt 72pt;">Nominal Defendant.</p></td><td style="vertical-align:middle;width:50%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt 0pt 0pt 7.2pt;">C.A. No. 2022-0135-KSJM</p></td></tr><tr><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:6pt 0pt 12pt 0pt;"><font style="text-transform:uppercase;">PAUL JOHN M. PAGUIA, </font>derivatively on behalf of <font style="text-transform:uppercase;">AYTU BIOPHARMA, INC., </font>and directly on behalf of himself and all others similarly situated,</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 0pt 0pt 72pt;">Plaintiff,</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">v.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt 0pt 12pt 0pt;">GARY CANTRELL, JOSHUA DISBROW, CARL DOCKERY, JOHN DONOFRIO, JR., AND MICHAEL MACALUSO,</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 0pt 12pt 72pt;">Defendants,</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">and</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">AYTU BIOPHARMA, INC.,</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 0pt 12pt 72pt;">Nominal Defendant.</p></td><td style="vertical-align:middle;width:50%;border-left:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt 0pt 0pt 7.2pt;">C.A. No. 2022-0200-KSJM</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:8.82%;padding-right:8.82%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;text-align:center;margin:12pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">NOTICE OF PENDENCY OF SETTLEMENT OF ACTIONS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">TO: ALL RECORD AND BENEFICIAL OWNERS OF AYTU BIOPHARMA, INC. COMMON STOCK (TRADING SYMBOL: AYTU) AND ALL AYTU CLASS MEMBERS AS OF APRIL 16, 2021.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. YOUR RIGHTS WILL BE AFFECTED BY THE LEGAL PROCEEDINGS IN THIS LITIGATION. IF THE COURT APPROVES THE PROPOSED SETTLEMENT,</b><sup style="font-size:10.5pt;font-weight:bold;vertical-align:top;"><a style="vertical-align:super;" href="#footnote-2">1</a></sup><b style="font-weight:bold;"> YOU WILL BE FOREVER BARRED FROM CONTESTING THE FAIRNESS, REASONABLENESS, AND ADEQUACY OF THE PROPOSED SETTLEMENT, OR PURSUING THE CLAIMS DEFINED HEREIN.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">IF YOU HOLD AYTU BIOPHARMA, INC. COMMON STOCK FOR THE BENEFIT OF ANOTHER, PLEASE PROMPTLY TRANSMIT THIS DOCUMENT TO SUCH BENEFICIAL OWNER.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">IF YOU DO NOT OBJECT TO THE PROPOSED SETTLEMENT, OR THE AGREED-TO ATTORNEYS&#8217; FEE AND EXPENSE AMOUNT DESCRIBED IN THIS NOTICE, YOU ARE NOT OBLIGATED TO TAKE ANY</b><b style="font-weight:bold;letter-spacing:-1.45pt;"> </b><b style="font-weight:bold;">ACTION.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">PLEASE NOTE: THERE IS NO PROOF OF CLAIM FORM FOR AYTU STOCKHOLDERS OR CLASS MEMBERS TO SUBMIT IN CONNECTION WITH THIS SETTLEMENT AND AYTU STOCKHOLDERS OR CLASS MEMBERS ARE NOT REQUIRED TO TAKE ANY ACTION IN RESPONSE TO THIS NOTICE.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><div style="margin-bottom:5pt;margin-top:15pt;width:25%;border-bottom:1px solid black;"></div><a name="footnote-2"></a><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt;"><sup style="font-size:10.5pt;vertical-align:top;">1</sup> Any capitalized terms used in this Notice that are not otherwise defined herein shall have the meanings ascribed to them in the Stipulation of Compromise and Settlement, dated December 19, 2022 (the &#8220;Stipulation&#8221;). A copy of the Stipulation is available at: https://aytubio.com.</p></div><div style="clear:both;margin-bottom:21.6pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.82%;margin-right:8.82%;margin-top:30pt;page-break-after:always;width:82.35%;border-width:0;"><div style="max-width:100%;padding-left:8.82%;padding-right:8.82%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;"><b style="color:#010000;font-family:'Times New Roman Bold';font-weight:bold;text-transform:uppercase;">I.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">WHY ARE YOU RECEIVING THIS</b><b style="font-weight:bold;letter-spacing:-0.5pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">NOTICE?</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The purpose of this Notice is to inform you about (i) two lawsuits (the &#8220;Actions&#8221;) in the Court of Chancery of the State of Delaware (the &#8220;Court&#8221;) brought on behalf of Aytu BioPharma, Inc. (&#8220;Aytu,&#8221; &#8220;Nominal Defendant,&#8221; or the &#8220;Company&#8221;); (ii) the proposed Settlement, subject to Court approval, on the terms and conditions set forth in the Stipulation of Compromise and Settlement (the &#8220;Stipulation&#8221;); (iii) the Court&#8217;s preliminary certification of the Class in connection with the proposed Settlement; (iv) Aytu stockholders&#8217; and Class Members&#8217; rights with respect to the proposed Settlement and Plaintiffs&#8217; Counsel&#8217;s Fee and Expense Amount; and (v)&#160;your right, among<font style="letter-spacing:2.65pt;"> </font>other<font style="letter-spacing:2.6pt;"> </font>things,<font style="letter-spacing:2.75pt;"> </font>to<font style="letter-spacing:2.65pt;"> </font>attend<font style="letter-spacing:2.6pt;"> </font>and<font style="letter-spacing:2.55pt;"> </font>participate in<font style="letter-spacing:2.65pt;"> </font>a hearing<font style="letter-spacing:2.65pt;"> </font>to<font style="letter-spacing:2.6pt;"> </font>be<font style="letter-spacing:2.6pt;"> </font>held<font style="letter-spacing:2.65pt;"> </font>on March 10, 2023 at 11:00 a.m., in the Court of Chancery, Leonard L. Williams Justice Center, 500 North King Street, Wilmington, Delaware 19801 (the &#8220;Settlement<font style="letter-spacing:-0.1pt;"> </font>Hearing&#8221;), at which the Court will (a) determine whether the proposed Settlement, on the terms and conditions provided for in the Stipulation, is fair, reasonable, and adequate and in the best interests of Aytu, its stockholders and the Class Members; (b) determine whether the Actions should be permanently maintained as non-opt-out class actions and whether the Class should be certified permanently, for purposes of the Settlement only, pursuant to Court of Chancery Rules 23(a), 23(b)(1) and (b)(2); (c) determine whether Plaintiffs should be permanently designated as representatives for the Class and Plaintiffs&#8217; Counsel as counsel for the Class, and to determine whether Plaintiffs and Plaintiffs&#8217; Counsel have adequately represented the interests of the Class in the Actions; (d) approve the form and content of the Notice of the Settlement to the stockholders and the Class; (e) determine whether the Court should finally approve the Stipulation and enter the Order and Final Judgment (the &#8220;Final Judgment&#8221;) substantially in the form attached as Exhibit C to the Stipulation, dismissing the Actions with prejudice and extinguishing and releasing the Released Claims; (f) hear and determine any objections to the proposed Settlement; (g) determine whether the Court should approve Plaintiffs&#8217; Counsel&#8217;s application for approval of the Fee and Expense Amount agreed upon by the Settling Parties; and (h) rule on such other matters as the Court may deem appropriate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">This<font style="letter-spacing:-0.4pt;"> </font>Notice<font style="letter-spacing:-0.5pt;"> </font>describes<font style="letter-spacing:-0.45pt;"> </font>the<font style="letter-spacing:-0.45pt;"> </font>rights<font style="letter-spacing:-0.35pt;"> </font>you<font style="letter-spacing:-0.4pt;"> </font>may<font style="letter-spacing:-0.35pt;"> </font>have<font style="letter-spacing:-0.4pt;"> </font>under<font style="letter-spacing:-0.4pt;"> </font>the<font style="letter-spacing:-0.4pt;"> </font>Stipulation<font style="letter-spacing:-0.35pt;"> </font>and<font style="letter-spacing:-0.5pt;"> </font>what steps you may, but are not required to, take concerning the proposed Settlement. If the<font style="letter-spacing:-0.8pt;"> </font>Court<font style="letter-spacing:-0.75pt;"> </font>approves<font style="letter-spacing:-0.75pt;"> </font>the<font style="letter-spacing:-0.75pt;"> </font>Stipulation,<font style="letter-spacing:-0.8pt;"> </font>the<font style="letter-spacing:-0.8pt;"> </font>parties<font style="letter-spacing:-0.75pt;"> </font>will<font style="letter-spacing:-0.7pt;"> </font>ask<font style="letter-spacing:-0.85pt;"> </font>the<font style="letter-spacing:-0.8pt;"> </font>Court<font style="letter-spacing:-0.75pt;"> </font>to<font style="letter-spacing:-0.7pt;"> </font>approve<font style="letter-spacing:-0.8pt;"> </font>the Final Judgment that would end the<font style="letter-spacing:-0.15pt;"> </font>Actions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:21.6pt;min-height:32.4pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:12pt 0pt 0pt 0pt;">-2-</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.82%;margin-right:8.82%;margin-top:30pt;page-break-after:always;width:82.35%;border-width:0;"><div style="max-width:100%;padding-left:8.82%;padding-right:8.82%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;"><b style="color:#010000;font-family:'Times New Roman Bold';font-weight:bold;text-transform:uppercase;">II.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">BACKGROUND: WHAT ARE THE ACTIONS</b><b style="font-weight:bold;letter-spacing:-0.3pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ABOUT?</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 36pt 12pt 36pt;"><b style="font-weight:bold;">THE FOLLOWING DESCRIPTION DOES NOT CONSTITUTE FINDINGS OF</b><b style="font-weight:bold;letter-spacing:-0.9pt;"> </b><b style="font-weight:bold;">ANY</b><b style="font-weight:bold;letter-spacing:-0.85pt;"> </b><b style="font-weight:bold;">COURT.</b><b style="font-weight:bold;letter-spacing:1.75pt;"> </b><b style="font-weight:bold;">IT</b><b style="font-weight:bold;letter-spacing:-0.8pt;"> </b><b style="font-weight:bold;">IS</b><b style="font-weight:bold;letter-spacing:-0.95pt;"> </b><b style="font-weight:bold;">BASED</b><b style="font-weight:bold;letter-spacing:-0.85pt;"> </b><b style="font-weight:bold;">ON</b><b style="font-weight:bold;letter-spacing:-0.75pt;"> </b><b style="font-weight:bold;">STATEMENTS</b><b style="font-weight:bold;letter-spacing:-0.95pt;"> </b><b style="font-weight:bold;">OF</b><b style="font-weight:bold;letter-spacing:-0.85pt;"> </b><b style="font-weight:bold;">THE</b><b style="font-weight:bold;letter-spacing:-0.8pt;"> </b><b style="font-weight:bold;">PARTIES</b><b style="font-weight:bold;letter-spacing:-0.95pt;"> </b><b style="font-weight:bold;">AND SHOULD NOT BE UNDERSTOOD AS AN EXPRESSION OF ANY OPINION OF ANY COURT AS TO THE MERITS OF ANY OF THE CLAIMS OR DEFENSES RAISED BY ANY OF THE</b><b style="font-weight:bold;letter-spacing:-0.8pt;"> </b><b style="font-weight:bold;">PARTIES.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Plaintiffs are Rafal Aponowicz and Paul John M. Paguia. Nominal Defendant Aytu<font style="letter-spacing:-0.3pt;"> </font>is a Delaware corporation with its principal place of business in Englewood, Colorado. It is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address needs in both prescription and consumer health categories. Gary Cantrell, Joshua Disbrow, Carl Dockery, John Donofrio, Jr. and Michael Macaluso (together, the &#8220;Individual Defendants&#8221; and, together with Aytu, the &#8220;Defendants&#8221;) are members of the Board of Directors of Aytu (the &#8220;Board&#8221;) and comprised the Board at the time the Actions were filed. Plaintiffs, Nominal Defendant Aytu, and the Individual Defendants are collectively referred to herein as the &#8220;Settling Parties.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">On February 9, 2022, Plaintiff Aponowicz filed a stockholder derivative and class action lawsuit titled<i style="font-style:italic;"> Aponowicz</i> <i style="font-style:italic;">v. Cantrell, et al</i>., No. 2022-0135-KSJM,<font style="letter-spacing:-0.4pt;"> </font>on<font style="letter-spacing:-0.3pt;"> </font>behalf<font style="letter-spacing:-0.3pt;"> </font>of<font style="letter-spacing:-0.3pt;"> </font>the Company, in the Court. On March 3, 2022, Plaintiff Paguia filed a stockholder derivative and class action lawsuit titled <i style="font-style:italic;">Paguia v. Cantrell, et al</i>., No. 2022-0200-KSJM<font style="letter-spacing:-0.4pt;"> </font>on<font style="letter-spacing:-0.3pt;"> behalf of </font>the Company, in the Court.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Actions allege that the Individual Defendants breached<font style="letter-spacing:-0.3pt;"> </font>their<font style="letter-spacing:-0.3pt;"> </font>fiduciary<font style="letter-spacing:-0.3pt;"> </font>duties<font style="letter-spacing:-0.3pt;"> </font>and<font style="letter-spacing:-0.3pt;"> </font>breached<font style="letter-spacing:-0.3pt;"> </font>a<font style="letter-spacing:-0.3pt;"> </font>contract<font style="letter-spacing:-0.35pt;"> </font>with the Company&#8217;s stockholders when they did not adjust the share reserve from 5,000,000<font style="letter-spacing:-0.25pt;"> </font>shares<font style="letter-spacing:-0.2pt;"> </font>to<font style="letter-spacing:-0.2pt;"> </font>500,000<font style="letter-spacing:-0.2pt;"> </font>shares<font style="letter-spacing:-0.25pt;"> </font>under<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.2pt;"> </font>2015<font style="letter-spacing:-0.2pt;"> </font>Stock<font style="letter-spacing:-0.2pt;"> </font>Option<font style="letter-spacing:-0.25pt;"> </font>and<font style="letter-spacing:-0.2pt;"> </font>Incentive<font style="letter-spacing:-0.2pt;"> </font>Plan (the &#8220;2015 Plan&#8221;) after implementing a reverse-stock split, violating the express terms of the<font style="letter-spacing:-0.1pt;"> 2015 </font>Plan. The Actions further allege that the Individual Defendants granted awards<font style="letter-spacing:-0.3pt;"> </font>in<font style="letter-spacing:-0.3pt;"> </font>excess<font style="letter-spacing:-0.3pt;"> </font>of<font style="letter-spacing:-0.35pt;"> </font>the<font style="letter-spacing:-0.3pt;"> </font>true<font style="letter-spacing:-0.3pt;"> </font>share<font style="letter-spacing:-0.35pt;"> </font>reserves<font style="letter-spacing:-0.4pt;"> </font>of<font style="letter-spacing:-0.35pt;"> </font>the<font style="letter-spacing:-0.35pt;"> 2015 </font>Plan,<font style="letter-spacing:-0.35pt;"> </font>thus<font style="letter-spacing:-0.35pt;"> </font>violating<font style="letter-spacing:-0.35pt;"> </font>the 2015 Plan and breaching their fiduciary duty under Delaware<font style="letter-spacing:-0.5pt;"> </font>law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Following the commencement of the Actions, counsel for the Settling Parties discussed a potential resolution of the Actions. Among other things, the Settling Parties&#8217; discussions focused on the<font style="letter-spacing:-0.4pt;"> </font>nature<font style="letter-spacing:-0.45pt;"> </font>of<font style="letter-spacing:-0.45pt;"> </font>the<font style="letter-spacing:-0.4pt;"> </font>potential<font style="letter-spacing:-0.5pt;"> </font>claims<font style="letter-spacing:-0.45pt;"> </font>at<font style="letter-spacing:-0.45pt;"> </font>issue,<font style="letter-spacing:-0.45pt;"> </font>the<font style="letter-spacing:-0.45pt;"> </font>potential<font style="letter-spacing:-0.45pt;"> </font>defenses to<font style="letter-spacing:-0.25pt;"> </font>those<font style="letter-spacing:-0.2pt;"> </font>claims,<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.25pt;"> </font>approximate<font style="letter-spacing:-0.15pt;"> </font>dollar<font style="letter-spacing:-0.15pt;"> </font>amounts<font style="letter-spacing:-0.15pt;"> </font>at<font style="letter-spacing:-0.2pt;"> </font>issue,<font style="letter-spacing:-0.15pt;"> </font>and<font style="letter-spacing:-0.2pt;"> </font>the<font style="letter-spacing:-0.25pt;"> </font>potential<font style="letter-spacing:-0.2pt;"> </font>costs<font style="letter-spacing:-0.2pt;"> </font>and expenses of litigation to<font style="letter-spacing:-0.25pt;"> </font>judgment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:21.6pt;min-height:32.4pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:12pt 0pt 0pt 0pt;">-3-</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.82%;margin-right:8.82%;margin-top:30pt;page-break-after:always;width:82.35%;border-width:0;"><div style="max-width:100%;padding-left:8.82%;padding-right:8.82%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Between<font style="letter-spacing:-0.3pt;"> </font>April<font style="letter-spacing:-0.3pt;"> </font>and<font style="letter-spacing:-0.15pt;"> </font>October<font style="letter-spacing:-0.25pt;"> </font>2022,<font style="letter-spacing:-0.3pt;"> </font>the<font style="letter-spacing:-0.3pt;"> </font>Settling<font style="letter-spacing:-0.3pt;"> </font>Parties<font style="letter-spacing:-0.25pt;"> </font>engaged<font style="letter-spacing:-0.3pt;"> </font>in<font style="letter-spacing:-0.3pt;"> </font>numerous rounds of negotiations, reaching an agreement in principle to settle all of the claims asserted in the Actions. Plaintiffs and Plaintiffs&#8217; Counsel believe that the Settlement is fair and adequate to the Company and its stockholders, and that it is appropriate and reasonable to pursue Court<font style="letter-spacing:-0.65pt;"> </font>approval<font style="letter-spacing:-0.6pt;"> </font>of<font style="letter-spacing:-0.65pt;"> </font>the<font style="letter-spacing:-0.75pt;"> </font>Settlement<font style="letter-spacing:-0.6pt;"> </font>based<font style="letter-spacing:-0.4pt;"> </font>on<font style="letter-spacing:-0.6pt;"> </font>the<font style="letter-spacing:-0.65pt;"> </font>terms<font style="letter-spacing:-0.6pt;"> </font>and<font style="letter-spacing:-0.75pt;"> </font>subject<font style="letter-spacing:-0.6pt;"> </font>to<font style="letter-spacing:-0.6pt;"> </font>the<font style="letter-spacing:-0.65pt;"> </font>conditions<font style="letter-spacing:-0.6pt;"> </font>set forth in the<font style="letter-spacing:-0.3pt;"> </font>Stipulation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 36pt 12pt 36pt;"><b style="font-weight:bold;">THE COURT HAS NOT FINALLY DETERMINED THE MERITS OF PLAINTIFFS&#8217; CLAIMS OR THE DEFENSES THERETO. THIS NOTICE DOES NOT IMPLY THAT THERE HAS BEEN OR WOULD BE ANY FINDING OF VIOLATION OF THE LAW BY THE INDIVIDUAL DEFENDANTS OR THAT RECOVERY COULD BE HAD IN ANY AMOUNT IF THE ACTIONS WERE NOT SETTLED.</b></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;"><b style="color:#010000;font-family:'Times New Roman Bold';font-weight:bold;text-transform:uppercase;">III.</b></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">HOW DO I KNOW IF I AM AFFECTED BY THE SETTLEMENT?</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">If you are a current Aytu stockholder or Class Member, you are subject to the Settlement. The Class preliminarily certified by the Court for purposes of the proposed Settlement consists of:</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 36pt 12pt 36pt;"><font style="text-decoration-color:#000000;">all record and beneficial owners of Aytu common stock as of April 16, 2021. Excluded from the Class are Defendants and any person, firm, trust, corporation, or other entity affiliated with them and their predecessors or successor in interest. &#8220;Class Member&#8221; means a Person who falls within the definition of the Class.</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">IV.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">WHAT ARE THE TERMS OF THE SETTLEMENT?</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">To settle the Actions, Defendants have agreed:</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;"><font style="color:#010000;">1.</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">The Board shall cancel 25% of the aggregate share awards challenged in the Actions, the resulting reduction to be allocated among Defendants as follows:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:21.6pt;min-height:32.4pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:12pt 0pt 0pt 0pt;">-4-</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.82%;margin-right:8.82%;margin-top:30pt;page-break-after:always;width:82.35%;border-width:0;"><div style="max-width:100%;padding-left:8.82%;padding-right:8.82%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="padding-left:36pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:54.22%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:43.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:25.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:30.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:43.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:25.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Granted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:30.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Rescinded</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:43.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;">Joshua Disbrow</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.75%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;">800,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:30.64%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;">80,000</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:43.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;">Gary Cantrell</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;">187,804</p></td><td style="vertical-align:bottom;white-space:nowrap;width:30.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;">40,000</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:43.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;">Carl Dockery</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;">187,804</p></td><td style="vertical-align:bottom;white-space:nowrap;width:30.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;">40,000</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:43.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;">John Donofrio</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;">187,804</p></td><td style="vertical-align:bottom;white-space:nowrap;width:30.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;">187,804</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:43.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;">Michael Macaluso</p></td><td style="vertical-align:bottom;white-space:nowrap;width:25.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;">187,804</p></td><td style="vertical-align:bottom;white-space:nowrap;width:30.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;">40,000</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:43.59%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:25.75%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><div style="padding-bottom:1.0px;border-bottom:3.0pt solid #000000;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;">1,551,216</p></div></td><td style="vertical-align:bottom;white-space:nowrap;width:30.64%;border-bottom:1.0pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"><div style="padding-bottom:1.0px;border-bottom:3.0pt solid #000000;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;">387,804</p></div></td></tr></table></div><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:14pt;text-align:justify;">2.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:14pt;text-align:justify;">The Company shall add to the Board two new directors who meet the NASDAQ standard of independence. One such new director has already been added to the Board and, within six months of the date of Final Court approval of the Settlement, shall serve as the Chair of the Board&#8217;s Compensation Committee. The other new director shall be appointed within six months of the date of Final Court approval of the Settlement and will also be appointed to the Compensation Committee.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">3.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">The Company shall designate a Lead Independent Director to coordinate the activities of the other independent directors and, among other things, to preside at all meetings of the Board when the Chair is not present, to call meetings of the independent directors, to retain advisors and consultants on behalf of the Board, to interview and make recommendations regarding director candidates, and to perform such other duties and responsibilities as the Board may determine. The Lead Independent Director shall be a director who meets the standard of &#8220;independence&#8221; under the NASDAQ rules. He or she may be removed or replaced from his/her position as Lead Independent Director at any time with or without cause by a majority vote of the Board.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">4.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">The Board shall adopt a new equity compensation plan and seek stockholder approval of this new plan at the Company&#8217;s next annual stockholder meeting. That plan shall include the following terms:</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">a.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">The plan administrator shall adjust the maximum number of shares reserved for issuance under the plan, in the event of any reorganization, reclassification, stock dividend, stock split, reverse stock split, or similar change in the Company&#8217;s capital stock, proportionately unless the Board&#8217;s Compensation Committee determines, in a good faith exercise of its sole discretion, that a fully proportional adjustment would not be</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:21.6pt;min-height:32.4pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:12pt 0pt 0pt 0pt;">-5-</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.82%;margin-right:8.82%;margin-top:30pt;page-break-after:always;width:82.35%;border-width:0;"><div style="max-width:100%;padding-left:8.82%;padding-right:8.82%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;margin:0pt 0pt 12pt 108pt;">conducive to retention and recruitment needs, in which case the Board&#8217;s Compensation Committee may make an adjustment that is not less than 50% of the number that would be fully proportional; and</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">b.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">The number of shares reserved for issuance under the plan shall not ever exceed 15% of the Company&#8217;s then total authorized and outstanding shares.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">5.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">The Board shall not award Defendants<font style="letter-spacing:-0.7pt;"> </font>any<font style="letter-spacing:-0.65pt;"> </font>further<font style="letter-spacing:-0.7pt;"> </font>equity<font style="letter-spacing:-0.65pt;"> </font>awards<font style="letter-spacing:-0.7pt;"> </font>under<font style="letter-spacing:-0.65pt;"> </font>the 2015<font style="letter-spacing:-0.65pt;"> </font>Plan.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">6.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">From 2022&#8211;2024, the Board shall limit to a maximum of $175,000 the total annual compensation (<i style="font-style:italic;">i.e.</i>, annual retainer, meeting fees, annual equity awards, etc.) payable to each of the Company&#8217;s non-employee directors.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">7.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">On at least a bi-annual basis (<i style="font-style:italic;">i.e.</i>, every other year), qualified experts in the field shall make a presentation to the Compensation<font style="letter-spacing:2.9pt;"> </font>Committee about recent developments and best practices concerning equity compensation practices.</p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">V.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">WHAT CLAIMS WILL THE SETTLEMENT RELEASE?</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-style:italic;font-weight:bold;">Under the Stipulation, the following releases will occur, except as noted below:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Releasing Persons (defined below) shall be deemed to have, and by operation of the Final Judgment shall have, fully, finally, and forever settled, released, discharged, extinguished, and dismissed with prejudice the Released Claims (defined below) against the Released Persons (defined below); provided, however, that such release shall not affect any claims to enforce the terms of the Stipulation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The<font style="letter-spacing:-0.45pt;"> </font>Released<font style="letter-spacing:-0.4pt;"> </font>Persons<font style="letter-spacing:-0.45pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>Aytu<font style="letter-spacing:-0.15pt;"> </font>shall<font style="letter-spacing:-0.4pt;"> </font>be<font style="letter-spacing:-0.45pt;"> </font>deemed<font style="letter-spacing:-0.5pt;"> </font>to<font style="letter-spacing:-0.55pt;"> </font>have,<font style="letter-spacing:-0.45pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>by<font style="letter-spacing:-0.55pt;"> </font>operation<font style="letter-spacing:-0.55pt;"> </font>of the Final Judgment shall have, fully, finally, and forever settled, released, discharged, extinguished, and dismissed with prejudice all claims (including Unknown Claims, as defined in the Stipulation), arising out of, relating to, or in connection with the institution, prosecution, assertion, settlement, or resolution of the Actions against the Releasing Persons and Plaintiffs&#8217; Counsel; provided, however, that such release shall not affect any claims to enforce the terms of the<font style="letter-spacing:-0.85pt;"> </font>Stipulation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:21.6pt;min-height:32.4pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:12pt 0pt 0pt 0pt;">-6-</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.82%;margin-right:8.82%;margin-top:30pt;page-break-after:always;width:82.35%;border-width:0;"><div style="max-width:100%;padding-left:8.82%;padding-right:8.82%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;Releasing Persons&#8221; means Plaintiffs (both individually, on behalf of the Class, and derivatively on behalf of Aytu), any Class Member, any other Aytu stockholder acting or purporting to act on behalf of Aytu, and Aytu. &#8220;Releasing Person&#8221; means, individually, any of the Releasing Persons.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;Released Persons&#8221; means each of the Individual Defendants and Aytu and their parents, subsidiaries, affiliates, predecessors, successors, and controlling persons, and each of their respective past or present officers, directors, employees, stockholders, family members, spouses, heirs, trusts, trustees, executors, beneficiaries, agents, representatives, partners, members, advisors, consultants, representatives, accountants, attorneys, insurers, and associates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;Released Claims&#8221; means and includes any and all manner of claims, causes of action, demands, rights, liabilities, losses, obligations, duties, damages, costs, debts,<font style="letter-spacing:-0.75pt;"> </font>penalties,<font style="letter-spacing:-0.75pt;"> </font>or<font style="letter-spacing:-0.65pt;"> </font>sanctions<font style="letter-spacing:-0.8pt;"> </font>of<font style="letter-spacing:-0.7pt;"> </font>any<font style="letter-spacing:-0.75pt;"> </font>kind,<font style="letter-spacing:-0.5pt;"> </font>nature,<font style="letter-spacing:-0.75pt;"> </font>or<font style="letter-spacing:-0.8pt;"> </font>description<font style="letter-spacing:-0.8pt;"> </font>whatsoever,<font style="letter-spacing:-0.7pt;"> </font>whether known<font style="letter-spacing:-0.5pt;"> </font>or<font style="letter-spacing:-0.55pt;"> </font>unknown,<font style="letter-spacing:-0.55pt;"> </font>disclosed<font style="letter-spacing:-0.5pt;"> </font>or<font style="letter-spacing:-0.5pt;"> </font>undisclosed,<font style="letter-spacing:-0.45pt;"> </font>accrued<font style="letter-spacing:-0.45pt;"> </font>or<font style="letter-spacing:-0.55pt;"> </font>unaccrued,<font style="letter-spacing:-0.45pt;"> </font>apparent<font style="letter-spacing:-0.45pt;"> </font>or<font style="letter-spacing:-0.55pt;"> </font>not apparent,<font style="letter-spacing:-0.8pt;"> </font>foreseen<font style="letter-spacing:-0.8pt;"> </font>or<font style="letter-spacing:-0.75pt;"> </font>unforeseen,<font style="letter-spacing:-0.8pt;"> </font>matured<font style="letter-spacing:-0.8pt;"> </font>or<font style="letter-spacing:-0.75pt;"> </font>not<font style="letter-spacing:-0.75pt;"> </font>matured,<font style="letter-spacing:-0.75pt;"> </font>suspected<font style="letter-spacing:-0.7pt;"> </font>or<font style="letter-spacing:-0.8pt;"> </font>unsuspected, liquidated or not liquidated, fixed or contingent, including Unknown Claims (as defined in the Stipulation), whether based on state, local, foreign, federal, statutory, regulatory,<font style="letter-spacing:-0.7pt;"> </font>common,<font style="letter-spacing:-0.65pt;"> </font>or<font style="letter-spacing:-0.6pt;"> </font>other<font style="letter-spacing:-0.6pt;"> </font>law<font style="letter-spacing:-0.7pt;"> </font>or<font style="letter-spacing:-0.6pt;"> </font>rule,<font style="letter-spacing:-0.65pt;"> </font>that<font style="letter-spacing:-0.7pt;"> </font>have<font style="letter-spacing:-0.6pt;"> </font>been<font style="letter-spacing:-0.6pt;"> </font>or<font style="letter-spacing:-0.6pt;"> </font>could<font style="letter-spacing:-0.6pt;"> </font>have<font style="letter-spacing:-0.75pt;"> </font>been<font style="letter-spacing:-0.6pt;"> </font>asserted by<font style="letter-spacing:-0.35pt;"> </font>Plaintiffs,<font style="letter-spacing:-0.4pt;"> any other Aytu stockholder </font>or<font style="letter-spacing:-0.4pt;"> </font>any<font style="letter-spacing:-0.3pt;"> </font>other<font style="letter-spacing:-0.35pt;"> </font>Class Member<font style="letter-spacing:-0.5pt;"> </font>or<font style="letter-spacing:-0.1pt;"> </font>any<font style="letter-spacing:-0.35pt;"> </font>other<font style="letter-spacing:-0.35pt;"> </font>Person<font style="letter-spacing:-0.35pt;"> individually or </font>acting<font style="letter-spacing:-0.3pt;"> </font>or<font style="letter-spacing:-0.4pt;"> </font>purporting to act on behalf of Aytu against the Released Persons in the Actions or in any other court, tribunal, or proceeding arising out of, based upon, or relating in any way to the allegations, actions, transactions, occurrences, statements, omissions, disclosures,<font style="letter-spacing:-0.95pt;"> </font>facts,<font style="letter-spacing:-0.9pt;"> </font>practices,<font style="letter-spacing:-0.9pt;"> </font>events,<font style="letter-spacing:-0.9pt;"> </font>or<font style="letter-spacing:-0.85pt;"> </font>claims<font style="letter-spacing:-0.85pt;"> </font>alleged<font style="letter-spacing:-0.8pt;"> </font>or<font style="letter-spacing:-0.85pt;"> </font>referred<font style="letter-spacing:-0.9pt;"> </font>to<font style="letter-spacing:-0.8pt;"> </font>in<font style="letter-spacing:-0.85pt;"> </font>the<font style="letter-spacing:-0.85pt;"> </font>Actions, including without limitation (i) with respect to the challenged awards under the 2015 Plan and<font style="letter-spacing:-0.3pt;"> </font>(ii)<font style="letter-spacing:-0.35pt;"> </font>any<font style="letter-spacing:-0.25pt;"> </font>decision<font style="letter-spacing:-0.3pt;"> </font>of<font style="letter-spacing:-0.3pt;"> </font>the<font style="letter-spacing:-0.3pt;"> </font>Company&#8217;s officers<font style="letter-spacing:-0.7pt;"> </font>or<font style="letter-spacing:-0.65pt;"> </font>directors<font style="letter-spacing:-0.65pt;"> </font>related<font style="letter-spacing:-0.65pt;"> </font>to<font style="letter-spacing:-0.7pt;"> </font>the<font style="letter-spacing:-0.65pt;"> </font>foregoing;<font style="letter-spacing:-0.8pt;"> </font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u>,<font style="letter-spacing:-0.75pt;"> </font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</u>,<font style="letter-spacing:-0.9pt;"> </font>that<font style="letter-spacing:-0.7pt;"> </font>it<font style="letter-spacing:-0.65pt;"> </font>is<font style="letter-spacing:-0.7pt;"> </font>understood that<font style="letter-spacing:-1.05pt;"> </font>&#8220;Released<font style="letter-spacing:-1.05pt;"> </font>Claims&#8221;<font style="letter-spacing:-1.05pt;"> </font>and<font style="letter-spacing:-1.05pt;"> </font>any<font style="letter-spacing:-1pt;"> </font>release<font style="letter-spacing:-1.2pt;"> </font>provided<font style="letter-spacing:-1.1pt;"> </font>by<font style="letter-spacing:-1.1pt;"> </font>this<font style="letter-spacing:-1.05pt;"> </font>Settlement<font style="letter-spacing:-1.05pt;"> </font>shall<font style="letter-spacing:-1.1pt;"> </font>not<font style="letter-spacing:-1.05pt;"> </font>include: (a) those claims asserted in <i style="font-style:italic;">Witmer v. Armistice Capital LLC, et al.</i>, No. 2022-<font style="color:#212121;">0807-MTZ</font> in the Delaware Court of Chancery, (b) any claims to enforce the Settlement, and (c) any claims by Defendants or any insured to enforce their rights under any contract or insurance policy.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">VI.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">WHAT ARE THE REASONS FOR THE SETTLEMENT?</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Plaintiffs&#8217; entry into the Stipulation and Settlement is not intended to be and shall<font style="letter-spacing:-0.8pt;"> </font>not<font style="letter-spacing:-0.85pt;"> </font>be<font style="letter-spacing:-0.85pt;"> </font>construed<font style="letter-spacing:-0.85pt;"> </font>as<font style="letter-spacing:-0.8pt;"> </font>an<font style="letter-spacing:-0.75pt;"> </font>admission<font style="letter-spacing:-0.8pt;"> </font>or<font style="letter-spacing:-0.8pt;"> </font>concession<font style="letter-spacing:-0.75pt;"> </font>concerning<font style="letter-spacing:-0.8pt;"> </font>the<font style="letter-spacing:-0.8pt;"> </font>relative<font style="letter-spacing:-0.85pt;"> </font>strength or merit of the claims alleged in the Actions. However, Plaintiffs and Plaintiffs&#8217; Counsel<font style="letter-spacing:-0.55pt;"> </font>also<font style="letter-spacing:-0.5pt;"> </font>recognize<font style="letter-spacing:-0.55pt;"> </font>and<font style="letter-spacing:-0.55pt;"> </font>acknowledge<font style="letter-spacing:-0.55pt;"> </font>the<font style="letter-spacing:-0.55pt;"> </font>significant<font style="letter-spacing:-0.5pt;"> </font>risk,<font style="letter-spacing:-0.65pt;"> </font>expense,<font style="letter-spacing:-0.55pt;"> </font>and<font style="letter-spacing:-0.5pt;"> </font>length<font style="letter-spacing:-0.5pt;"> </font>of continued<font style="letter-spacing:-1.1pt;"> </font>proceedings<font style="letter-spacing:-1.1pt;"> </font>necessary<font style="letter-spacing:-1.1pt;"> </font>to<font style="letter-spacing:-1.1pt;"> </font>prosecute<font style="letter-spacing:-1.1pt;"> </font>the<font style="letter-spacing:-1.15pt;"> </font>Actions<font style="letter-spacing:-1.1pt;"> </font>against<font style="letter-spacing:-1.15pt;"> </font>Defendants<font style="letter-spacing:-1.1pt;"> </font>through</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:21.6pt;min-height:32.4pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:12pt 0pt 0pt 0pt;">-7-</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.82%;margin-right:8.82%;margin-top:30pt;page-break-after:always;width:82.35%;border-width:0;"><div style="max-width:100%;padding-left:8.82%;padding-right:8.82%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">trial and through possible appeals. Plaintiffs&#8217; Counsel also have taken into account the<font style="letter-spacing:-1.05pt;"> </font>uncertain<font style="letter-spacing:-1pt;"> </font>outcome<font style="letter-spacing:-0.9pt;"> </font>and<font style="letter-spacing:-0.85pt;"> </font>the<font style="letter-spacing:-0.9pt;"> </font>risk<font style="letter-spacing:-0.85pt;"> </font>of<font style="letter-spacing:-1.05pt;"> </font>any<font style="letter-spacing:-0.85pt;"> </font>litigation,<font style="letter-spacing:-0.9pt;"> </font>especially<font style="letter-spacing:-0.85pt;"> </font>in<font style="letter-spacing:-1pt;"> </font>complex<font style="letter-spacing:-0.85pt;"> </font>cases<font style="letter-spacing:-0.85pt;"> </font>such as the Actions, as well as the difficulties and delays inherent in such litigation. Plaintiffs&#8217; Counsel also are mindful of the inherent problems of proof and possible defenses to the claims alleged in such Actions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Based on Plaintiffs&#8217; Counsel&#8217;s thorough review and analysis of the relevant facts, allegations, defenses, and controlling legal principles, Plaintiffs and Plaintiffs&#8217; Counsel have determined that the Settlement set forth in the Stipulation is fair, reasonable, and adequate, and in the best interests of Aytu, its stockholders and the Class Members and that the Settlement confers benefits upon Aytu, its stockholders and the Class Members and Plaintiffs have agreed to settle the Actions on the terms and subject to the conditions set forth in the Stipulation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Each of the Individual Defendants has denied, and continues to deny, that they have committed any breach of fiduciary duty or any other duty owed to Aytu, its stockholders or the Class Members, that they breached any contract, or that they committed <font style="letter-spacing:-0.15pt;">any </font>violations of law or wrongdoing whatsoever or that Aytu or Aytu&#8217;s stockholders or the Class Members suffered any damage or harm as a result of any act, omission, or conduct alleged in the Actions or otherwise. The Individual Defendants have further asserted, and continue to assert, that at all relevant times, they have acted in good faith and in a manner that they believed to be in the best interests of Aytu, its stockholders and the Class Members, and that they are entering into the Stipulation and the Settlement solely to eliminate the<font style="letter-spacing:-0.4pt;"> </font>uncertainty,<font style="letter-spacing:-0.4pt;"> </font>distraction,<font style="letter-spacing:-0.25pt;"> </font>disruption,<font style="letter-spacing:-0.3pt;"> </font>burden,<font style="letter-spacing:-0.25pt;"> </font>expense,<font style="letter-spacing:-0.25pt;"> </font>and<font style="letter-spacing:-0.3pt;"> </font>risk<font style="letter-spacing:-0.15pt;"> </font>inherent<font style="letter-spacing:-0.15pt;"> </font>in<font style="letter-spacing:-0.2pt;"> </font>further litigation.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">VII.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">HOW WILL THE ATTORNEYS GET PAID?</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">After agreeing to the terms of the Settlement,<font style="letter-spacing:-0.85pt;"> </font>Plaintiffs&#8217;<font style="letter-spacing:-0.8pt;"> </font>Counsel<font style="letter-spacing:-0.8pt;"> </font>and<font style="letter-spacing:-0.6pt;"> </font>Aytu separately<font style="letter-spacing:-0.7pt;"> </font>began<font style="letter-spacing:-0.85pt;"> </font>negotiating the amount of the award of attorneys&#8217; fees and expenses to be paid to Plaintiffs&#8217; Counsel. The Settling Parties did not discuss the appropriateness or amount of attorneys&#8217; fees and expenses to be paid to Plaintiffs&#8217; Counsel until after reaching agreement on the terms of the Settlement, and the Settling Parties understood at all times that the Settlement was not contingent upon agreement or payment of any attorneys&#8217; fees and expenses to Plaintiffs&#8217; Counsel. Defendants acknowledge and agree<font style="letter-spacing:-0.5pt;"> </font>that<font style="letter-spacing:-0.35pt;"> </font>Plaintiffs&#8217;<font style="letter-spacing:-0.45pt;"> </font>Counsel<font style="letter-spacing:-0.35pt;"> </font>are<font style="letter-spacing:-0.3pt;"> </font>entitled<font style="letter-spacing:-0.45pt;"> </font>to<font style="letter-spacing:-0.35pt;"> </font>a<font style="letter-spacing:-0.4pt;"> </font>fee<font style="letter-spacing:-0.45pt;"> </font>award.<font style="letter-spacing:2.6pt;"> </font>In<font style="letter-spacing:-0.35pt;"> </font>recognition<font style="letter-spacing:-0.45pt;"> </font>of<font style="letter-spacing:-0.35pt;"> </font>the<font style="letter-spacing:-0.5pt;"> </font>terms of the Settlement and the prosecution and settlement of the Actions, and subject to Court<font style="letter-spacing:-0.4pt;"> </font>approval,<font style="letter-spacing:-0.3pt;"> </font>Aytu has<font style="letter-spacing:-0.45pt;"> </font>agreed<font style="letter-spacing:-0.35pt;"> </font>to<font style="letter-spacing:-0.35pt;"> </font>pay<font style="letter-spacing:-0.4pt;"> </font>an<font style="letter-spacing:-0.45pt;"> </font>award<font style="letter-spacing:-0.45pt;"> </font>of<font style="letter-spacing:-0.4pt;"> </font>attorneys&#8217;<font style="letter-spacing:-0.4pt;"> </font>fees<font style="letter-spacing:-0.3pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>expenses<font style="letter-spacing:-0.45pt;"> </font>to Plaintiffs&#8217; Counsel not to exceed $425,000 (the &#8220;Fee and Expense Amount&#8221;). The Fee and Expense Amount includes the fees and expenses incurred by Plaintiffs&#8217; Counsel in connection with the prosecution and</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:21.6pt;min-height:32.4pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:12pt 0pt 0pt 0pt;">-8-</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.82%;margin-right:8.82%;margin-top:30pt;page-break-after:always;width:82.35%;border-width:0;"><div style="max-width:100%;padding-left:8.82%;padding-right:8.82%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">settlement of the Actions. Plaintiffs&#8217; Counsel will not seek fees or<font style="letter-spacing:-0.85pt;"> </font>expenses<font style="letter-spacing:-0.8pt;"> </font>from<font style="letter-spacing:-0.85pt;"> </font>the<font style="letter-spacing:-0.95pt;"> </font>Court<font style="letter-spacing:-0.8pt;"> </font>in<font style="letter-spacing:-0.8pt;"> </font>excess<font style="letter-spacing:-0.9pt;"> </font>of<font style="letter-spacing:-0.85pt;"> </font>the<font style="letter-spacing:-0.85pt;"> </font>agreed-to<font style="letter-spacing:-0.8pt;"> </font>amount<font style="letter-spacing:-0.75pt;"> </font>and<font style="letter-spacing:-0.9pt;"> </font>Plaintiffs&#8217;<font style="letter-spacing:-0.85pt;"> </font>Counsel will<font style="letter-spacing:-0.85pt;"> </font>not<font style="letter-spacing:-0.7pt;"> </font>make<font style="letter-spacing:-0.75pt;"> </font>an<font style="letter-spacing:-0.75pt;"> </font>application<font style="letter-spacing:-0.7pt;"> </font>for<font style="letter-spacing:-0.75pt;"> </font>attorneys&#8217;<font style="letter-spacing:-0.8pt;"> </font>fees<font style="letter-spacing:-0.7pt;"> </font>or<font style="letter-spacing:-0.75pt;"> </font>expenses<font style="letter-spacing:-0.75pt;"> </font>in<font style="letter-spacing:-0.7pt;"> </font>any<font style="letter-spacing:-0.7pt;"> </font>other<font style="letter-spacing:-0.8pt;"> </font>jurisdiction. Except as otherwise provided herein, each of the Parties shall bear his, her, or its own fees and<font style="letter-spacing:0.1pt;"> </font>costs.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">VIII.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">WHEN WILL THE SETTLEMENT HEARING TAKE PLACE?</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Court has scheduled a Settlement Hearing to be held on March 10, 2023 at 11:00 a.m., in the Court of Chancery, Leonard L. Williams Justice Center, 500 North King Street, Wilmington, Delaware 19801.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">At the Settlement Hearing, the Court will consider whether the terms of the Settlement are fair, reasonable, and adequate and thus should be finally approved, whether the Fee and Expense Amount should be approved, and whether the Actions should be dismissed with prejudice by entry of the Final Judgment pursuant to the Stipulation. The Court will also hear and determine objections, if any, to the proposed<font style="letter-spacing:-0.35pt;"> </font>Settlement<font style="letter-spacing:-0.4pt;"> </font>or<font style="letter-spacing:-0.4pt;"> </font>the<font style="letter-spacing:-0.4pt;"> </font>Fee<font style="letter-spacing:-0.4pt;"> </font>and<font style="letter-spacing:-0.45pt;"> </font>Expense<font style="letter-spacing:-0.45pt;"> </font>Amount<font style="letter-spacing:-0.15pt;"> </font>and<font style="letter-spacing:-0.4pt;"> </font>rule<font style="letter-spacing:-0.5pt;"> </font>on<font style="letter-spacing:-0.35pt;"> </font>such<font style="letter-spacing:-0.45pt;"> </font>other<font style="letter-spacing:-0.4pt;"> </font>matters as the Court may deem<font style="letter-spacing:-0.1pt;"> </font>appropriate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Court may adjourn the Settlement Hearing from time to time without further<font style="letter-spacing:-0.65pt;"> </font>notice<font style="letter-spacing:-0.65pt;"> </font>to<font style="letter-spacing:-0.6pt;"> </font>anyone<font style="letter-spacing:-0.65pt;"> </font>other<font style="letter-spacing:-0.6pt;"> </font>than<font style="letter-spacing:-0.65pt;"> </font>the<font style="letter-spacing:-0.5pt;"> </font>Settling<font style="letter-spacing:-0.6pt;"> </font>Parties<font style="letter-spacing:-0.55pt;"> </font>and<font style="letter-spacing:-0.65pt;"> </font>any<font style="letter-spacing:-0.7pt;"> </font>Objectors<font style="letter-spacing:-0.65pt;"> </font>(as<font style="letter-spacing:-0.7pt;"> </font>defined below).<font style="letter-spacing:0.55pt;"> </font>The Court reserves the right to approve the Stipulation at or after the Settlement Hearing with such modifications as may be consented to by the Settling Parties to the Stipulation and without further notice.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">IX.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">DO I HAVE A RIGHT TO APPEAR AND OBJECT?</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Any Aytu stockholder or Class Member who objects to the Settlement, the proposed Final Judgment to be entered, the Fee and Expense Amount, and/or who otherwise wishes to be heard (an &#8220;Objector&#8221;), may appear in person or by his, her, or its attorney at the Settlement Hearing and present any evidence or argument that may be proper and relevant; <i style="font-style:italic;">provided, however</i>, that no Objector shall be heard or entitled to contest the approval of the terms and conditions of the Settlement, or, if approved, the Final Judgment to be entered thereon, unless he, she, or it has, no later than ten (10) calendar days before the Settlement Hearing (unless the Court in its discretion shall thereafter otherwise direct, upon application of such person and for good cause shown), filed with the Register in Chancery, Court of Chancery, Leonard L. Williams Justice Center, 500 North King Street, Wilmington, Delaware 19801, and served (by hand or overnight mail) on Plaintiffs&#8217; Counsel and Defendants&#8217; counsel, at the addresses below, the following: (i) proof of current ownership of Aytu</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:21.6pt;min-height:32.4pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:12pt 0pt 0pt 0pt;">-9-</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.82%;margin-right:8.82%;margin-top:30pt;page-break-after:always;width:82.35%;border-width:0;"><div style="max-width:100%;padding-left:8.82%;padding-right:8.82%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">stock;<font style="letter-spacing:-0.45pt;"> </font>(ii)<font style="letter-spacing:-0.15pt;"> </font>a<font style="letter-spacing:-0.6pt;"> </font>written<font style="letter-spacing:-0.65pt;"> and signed </font>notice<font style="letter-spacing:-0.6pt;"> </font>of<font style="letter-spacing:-0.6pt;"> </font>the<font style="letter-spacing:-0.55pt;"> </font>Objector&#8217;s<font style="letter-spacing:-0.45pt;"> </font>intention<font style="letter-spacing:-0.6pt;"> </font>to<font style="letter-spacing:-0.65pt;"> </font>appear, which states the name, address, and telephone number of the Objector and, if represented by counsel, the name, address, and telephone number of his, her, or its counsel;<font style="letter-spacing:-0.45pt;"> </font>(iii)<font style="letter-spacing:0.1pt;"> </font>a<font style="letter-spacing:-0.6pt;"> </font>detailed statement of the objections to any matter before the Court; and (iv) a detailed statement of all of the grounds thereon and the reasons for the Objector&#8217;s desire to appear and to be heard, as well as all documents or writings which the Objector desires the Court to consider. In addition to the aforementioned Court address, the addresses to which such information should be sent are <font style="letter-spacing:0.15pt;">as</font><font style="letter-spacing:-0.45pt;"> </font>follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt 0pt 12pt 36pt;">Brian D. Long<br>LONG LAW, LLC<br>3828 Kennett Pike, Suite 208<br>Wilmington, DE 19807<br>Telephone: (302) 729-9100<br>bdlong@longlawde.com<br>Attorneys for Plaintiff Rafal Aponowicz</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt 0pt 12pt 36pt;">Kathleen Miller<br>Robert K. Beste<br>SMITH, KATZENSTEIN &amp; JENKINS LLP<br>1000 N. West Street, Suite 1501<br>P.O. Box 410<br>Wilmington, DE 19899<br>Telephone: (302) 652-8400<br>KMM@skjlaw.com<br>RKB@skjlaw.com<br>Attorneys for Plaintiff Paul John M. Paguia</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt 0pt 12pt 36pt;">Eric Lopez Schnabel<br>DORSEY &amp; WHITNEY LLP<br>300 Delaware Avenue, Suite 1010<br>Wilmington, DE 19801<br>Telephone: (302) 425-7171<br>Fax: (302) 425-7177<br>schnabel.eric@dorsey.com<br>Attorneys for Defendants</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Any person or entity who fails to object in the manner prescribed above shall be deemed to have waived such objection (including the right to appeal), unless the Court in its discretion allows such objection to be heard at the Settlement Hearing,</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:21.6pt;min-height:32.4pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:12pt 0pt 0pt 0pt;">-10-</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.82%;margin-right:8.82%;margin-top:30pt;page-break-after:always;width:82.35%;border-width:0;"><div style="max-width:100%;padding-left:8.82%;padding-right:8.82%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">and shall forever be barred from raising such objection in the Actions or any other action<font style="letter-spacing:-0.3pt;"> </font>or<font style="letter-spacing:-0.3pt;"> </font>proceeding<font style="letter-spacing:-0.35pt;"> </font>or<font style="letter-spacing:-0.3pt;"> </font>otherwise<font style="letter-spacing:-0.25pt;"> </font>contesting<font style="letter-spacing:-0.3pt;"> </font>the<font style="letter-spacing:-0.25pt;"> </font>Stipulation<font style="letter-spacing:-0.3pt;">, </font>the<font style="letter-spacing:-0.25pt;"> </font>Fee<font style="letter-spacing:-0.3pt;"> </font>and<font style="letter-spacing:-0.25pt;"> </font>Expense Amount<font style="letter-spacing:-0.7pt;"> or any other matter related to the Settlement, in the Actions or any other action or proceeding, </font>and<font style="letter-spacing:-0.7pt;"> </font>will<font style="letter-spacing:-0.7pt;"> </font>otherwise<font style="letter-spacing:-0.75pt;"> </font>be<font style="letter-spacing:-0.75pt;"> </font>bound<font style="letter-spacing:-0.7pt;"> </font>by<font style="letter-spacing:-0.7pt;"> </font>the<font style="letter-spacing:-0.65pt;"> Final </font>Judgment<font style="letter-spacing:-0.7pt;"> </font>to<font style="letter-spacing:-0.7pt;"> </font>be<font style="letter-spacing:-0.75pt;"> </font>entered<font style="letter-spacing:-0.7pt;"> </font>and<font style="letter-spacing:-0.7pt;"> </font>the<font style="letter-spacing:-0.65pt;"> </font>releases to be given. You are not required to appear in person at the Settlement Hearing in order to have your timely and properly filed objection<font style="letter-spacing:-0.5pt;"> </font>considered.</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">X.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">HOW DO I GET ADDITIONAL INFORMATION ABOUT THE SETTLEMENT?</b></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">This Notice contains only a summary of the terms of the proposed Settlement. It is not a complete statement of the events of the Actions or the Stipulation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For additional information about the claims asserted in the Actions and the terms<font style="letter-spacing:-0.3pt;"> </font>of<font style="letter-spacing:-0.4pt;"> </font>the<font style="letter-spacing:-0.25pt;"> </font>proposed<font style="letter-spacing:-0.35pt;"> </font>Settlement,<font style="letter-spacing:-0.35pt;"> </font>please<font style="letter-spacing:-0.25pt;"> </font>refer<font style="letter-spacing:-0.25pt;"> </font>to<font style="letter-spacing:-0.3pt;"> </font>the<font style="letter-spacing:-0.4pt;"> </font>documents<font style="letter-spacing:-0.25pt;"> </font>filed<font style="letter-spacing:-0.35pt;"> </font>with<font style="letter-spacing:-0.25pt;"> </font>the<font style="letter-spacing:-0.3pt;"> </font>Court and the Stipulation. You may examine the Court files during regular business hours of each business day at the Office of the Register in Chancery in the Court of Chancery of the State of Delaware, Leonard L. Williams Justice Center, 500 North King Street, Wilmington, Delaware 19801. However, you must appear in person to inspect these documents. The Clerk&#8217;s office will not mail copies to<font style="letter-spacing:0.05pt;"> </font>you.</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">For more information concerning the Settlement, you may also call or write to the two Plaintiffs&#8217; Counsel:</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt 0pt 12pt 36pt;">Shane T. Rowley <br>Danielle Rowland Lindahl<br>ROWLEY LAW PLLC <br>50 Main Street, Suite 1000<br>White Plains, NY 10606<br>Tel: (914) 400-1920<br>Fax: (914) 301-3514<br>Attorneys for Plaintiff Rafal Aponowicz</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:21.6pt;min-height:32.4pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:12pt 0pt 0pt 0pt;">-11-</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.82%;margin-right:8.82%;margin-top:30pt;page-break-after:always;width:82.35%;border-width:0;"><div style="max-width:100%;padding-left:8.82%;padding-right:8.82%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt 0pt 12pt 36pt;">Eric L. Zagar<br>J. Daniel Albert<br>Kevin E.T. Cunningham, Jr.<br>KESSLER TOPAZ MELTZER &amp; CHECK, LLP<br>280 King of Prussia Road<br>Radnor, PA 19087<br>Telephone: (610) 667-7706<br>Attorneys for Plaintiff Paul John M. Paguia</p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><font style="font-style:italic;font-weight:bold;">PLEASE DO NOT WRITE OR CALL THE COURT OR THE OFFICE OF THE REGISTER IN CHANCERY REGARDING THIS NOTICE.</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;width:100%;" align="center"><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:14pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:14pt;">BY ORDER OF THE COURT OF CHANCERY OF THE STATE OF DELAWARE</font></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:14pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:14pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:14pt;">Dated: December 28, 2022.</font></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:14pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:14pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:14pt;">Register in Chancery</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:21.6pt;min-height:32.4pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:12pt 0pt 0pt 0pt;">-12-</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:8.82%;margin-right:8.82%;margin-top:30pt;page-break-after:avoid;width:82.35%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>aytu-20221228.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.1.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 12/28/2022 6:05:26 PM-->
<!--Modified on: 12/28/2022 6:05:26 PM-->
<xsd:schema targetNamespace="http://www.aytubio.com/20221228" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:srt-roles="http://fasb.org/srt-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:aytu="http://www.aytubio.com/20221228" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.aytubio.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="aytu-20221228_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aytu-20221228_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>aytu-20221228_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.1.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 12/28/2022 6:05:26 PM-->
<!--Modified on: 12/28/2022 6:05:26 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cover [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Adress Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>aytu-20221228_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.1.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 12/28/2022 6:05:26 PM-->
<!--Modified on: 12/28/2022 6:05:26 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="aytu-20221228.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.aytubio.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.aytubio.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638078475261081876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638078475261081876" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638078475261081876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638078475261081876" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638078475261081876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_638078475261081876" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638078475261081876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638078475261081876" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638078475261081876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638078475261081876" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638078475261081876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638078475261081876" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638078475261081876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638078475261081876" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_638078475261081876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine2_638078475261081876" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638078475261081876" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638078475261081876" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638078475261091927" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638078475261091927" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638078475261091927" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638078475261091927" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638078475261091927" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_638078475261091927" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638078475261091927" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_638078475261091927" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638078475261091927" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_WrittenCommunications_638078475261091927" order="14" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638078475261091927" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SolicitingMaterial_638078475261091927" order="15" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638078475261091927" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_638078475261091927" order="16" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638078475261091927" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638078475261091927" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638078475261091927" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_638078475261091927" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638078475261091927" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_638078475261091927" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638078475261101874" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_638078475261101874" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638078475261101874" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638078475261101874" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638078475261101874" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638078475261101874" order="22" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638078475261101874" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638078475261101874" order="23" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140589686149072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 28,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AYTU BIOPHARMA,&#160;INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-0883144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">373 Inverness Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Adress Line Two</a></td>
<td class="text">Suite&#160;206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Englewood<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">437-6580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AYTU<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001385818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>aytu-20221228x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aytu-20221228.xsd" xlink:type="simple"/>
    <context id="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001385818</identifier>
        </entity>
        <period>
            <startDate>2022-12-28</startDate>
            <endDate>2022-12-28</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Tc_mfdosfUR8U2uarKhlWZWXw_1_1">0001385818</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Tc_TreCait6okyxYSFGFVbzBQ_2_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_WfX4f9f4S0eA287wsXNRsw">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_mj9538zcM0CeOD97k8NWgg">2022-12-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_Vmqtgr0240yMAGAq42lfBw">AYTU BIOPHARMA,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Tc_4tcPL1VfqUSg2ULlPruGFg_1_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Tc_t8fG7H_KPkGuD6N0ufcR6Q_1_2">001-38247</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Tc_w-6vKU_cTEqiNvxthLbOPA_1_4">47-0883144</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_iVKpQL_ztU68PqGXiJ-QeA">373 Inverness Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_NPbG2Q0WnUeWYd4Y-1tiOA">Suite&#160;206</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_zDmCcVcm1UyDa6g56bcIyg">Englewood</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_kXiM1He5o0qcWWIc4jNtbA">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_KnqSyI0-oUSFz42WMospWg">80112</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_mnnBfTtGhka1n40-dLTstg">720</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_-2c1kTiFXkGnDMD3t6U5lA">437-6580</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_DmJQBTI5JkWUHe2kJ_1KDQ">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_dQdd-xm6R0mFv9XgAFuUnA">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_ndfAp2rsXkqGrDijljorNw">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_7VHnKnIr6Uudk6XYpo7H1g">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Tc_bWOA3VTT_0SYpyRUnljFjQ_2_0">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Tc_MnDKhzG0w0-VyZC0CpLtlQ_2_2">AYTU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Tc_KDiiNDTOw0OIx2bINSNZVw_2_4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg"
      id="Narr_eiUKS2yqsUSn-X_I07LZBQ">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ,>#GE4'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #'@YY5UDA)>^T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)OITG%0^CVLN))07!!\1:2V=U@TX1DI-VW-XV[740?P&-F_GSS
M#4RG@]0^XG/T 2-93#>S&\8D==BP(U&0 $D?T:E4Y\28FWL?G:+\C <(2G^H
M X)HFCMP2,HH4K  J[ 26=\9+75$13Z>\4:O^/ 9AP(S&G! AR,EX#4'UB\3
MPVD>.K@"%AAA=.F[@&8EENJ?V-(!=D[.R:ZI:9KJJ2VYO .'MZ?'E[)N9<=$
M:M28?R4KZ11PPRZ37]OM_>Z!]:(1HN*B:IN=X+)M)+]]7UQ_^%V%G3=V;_^Q
M\46P[^#77?1?4$L#!!0    ( ,>#GE697)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MP %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ QX.>59>*NQS     $P(
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MB^$_7G\!4$L! A0#%     @ QX.>50=!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #'@YY5UDA)>^T
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M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( ,>#GE67BKL<P    !,"   +
M      "  8P/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( ,>#GE4<.&7J/P$
M #P"   /              "  740  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " #'@YY5)!Z;HJT   #X 0  &@              @ 'A$0  >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #'@YY599!YDAD!  #/
M P  $P              @ '&$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    "0 ) #X"   0%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="aytu-20221228x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aytubio.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="aytu-20221228x8k.htm">aytu-20221228x8k.htm</File>
    <File>aytu-20221228.xsd</File>
    <File>aytu-20221228_lab.xml</File>
    <File>aytu-20221228_pre.xml</File>
    <File>aytu-20221228xex99d1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "aytu-20221228x8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "aytu-20221228x8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "aytu-20221228_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aytu-20221228_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "aytu-20221228.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "aytu",
   "nsuri": "http://www.aytubio.com/20221228",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aytu-20221228x8k.htm",
      "contextRef": "Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aytu-20221228x8k.htm",
      "contextRef": "Duration_12_28_2022_To_12_28_2022_T3PeKimPD0u9fugQuOmkcg",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Adress Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001558370-22-019046-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-22-019046-xbrl.zip
M4$L#!!0    ( ,>#GE4-'QJ7<0,  $\,   1    87ET=2TR,#(R,3(R."YX
M<V2U5EU/VS 4?9^T_^#E/9\5""H*&F.3D&";&)-XFUS';:TE=F8[M/S[73MQ
M6J=)Z:;MB>!S[O'QO;[7O;C:E 5ZIE(QP6=!&B4!HIR(G/'E+*A5B!5A++BZ
M?/OFXET8/ET_W*%<D+JD7",B*=8T1VNF5^A15!7FZ)Y*R8H"74N6+RE":1*!
M:#1!8=AJ7&,%,8(C*Y9%:8=\:/4$GZ(TB[.S.$NR#)U.DY-I=HJ^WG?,>S"X
M8*]3-RJ?*K*B)48:RR75GW%)584)G04KK:MI'*_7ZPB_Z'K.1$1$:772+#L+
M$-9:LGFMZ2<ARQNZP'6A(2?\5XT+NSNDJJ F$QYA!X;<<C4%$]YNZTDDY!(V
M2M+XZ?[NF_7GR)#R)<95%[# :F[I+6#].;*2.M0O%57[] [R D!$BF*([Q"/
M+NG"<[Z9R\)Y/XT![8X(0*X[[B[O)&Y 1R6UE'##7GRRHB1:BN?8H9Z-33'J
M8A(_W3'^TS$Y9D0-*UMH+WLCV>@@+X"(FFLYYKP!_71K.>K\/ 9TQ\J@"4^M
M@(,>2(2!Y]!;CDXW9#5LU2"]!/>EVSN:GI^?QQ;MG#(R+ I _ZJ-7$V'>'1.
MEZ;W#Z3+U"-N:9T;7<D1.X!X&QS1S:Y=V>OM&C*N-.:$[G8 .U"=/M^,G"-F
M4%M*7I?94'=E"1134Z[8O*"AH5&)-8QR%69FE#?AN9:]6GC^ (X-;/7") VS
MM(NDE:3DF,)LF=N*ZM>KJ;<[L>%" N#5,3_84_FVI\C.\/([E2[\VV_F$QL<
M7J?-\&(!/"8(V><$<RZTS;%=<ZM5Q?A"M$NP:'IF:@[Y")E%YN/[P^UHP6TV
M;MIWU?U]S_./7#/]<@O*LK1[!HA!*8YB=EZ<FYPN&&?6>0*Y2E"(G,#N)^8Y
M:M30CMQ%W-?HR]?PK'_AE_8;[H("+1MIYG,;W5(.11)<D+KXB\"ML_&X=M65
MI5<M-T ?Z +9F3<U73$+%"NKPC2N75O91]$4+W1M^@..&\%=<A2C?V 4V&+W
M,]1N["2P)'LJ>S,91$1%I68P2[?3/_YGQRKP_$^/!2&T^#_GN8C[C=:N^ UI
MVQ&.)J1&?._7WLAH:7XCW@EB=1JV&J.;#YND"+9R_@YO>^@]&-I[,,3\U[T[
MH5D*TRR<I,?;&/Y==J0!%V!V/MGNV12AT;C\#5!+ P04    " #'@YY5)1^P
M&G8%  !N/@  %0   &%Y='4M,C R,C$R,CA?;&%B+GAM;-6;X6_B-AC&OT_:
M__".?=FD"RFI[K2BMJ<>UYNJT2LZF';:-)U"8L!:L)%C"OSWLY,XD& '&GJ1
M^=(&WB>/W\?\E,0D7+]?SR-X1BS&E-RT.NV+%B 2T!"3Z4UK&3M^'&#<>G_[
MXP_7/SG.UP]?^A#28#E'A$/ D,]1""O,9S"BBX5/X!$QAJ,(/C <3A% YZ(M
M3-N7X#B9QP<_%OM0 HF9U^[DE5[F1TD7.I[K_>9Z%YX'[[H7;[O>.Q@\YLI'
MT> $'Y9&F/S7E7_&8E 044G<7<?XIC7C?-%UW=5JU5Y=MBF;BOTO.N[7Q_XP
MF*&Y[V 2<Y\$J 5"WXV3-_LT\'DR3SN[K\<L4@:7;CZ642%?.4KFR+><CN=<
M=MKK.&QE+<KR$8,HN:R&/-]A5_S638NY=,\ZB]^YNKIRDVI+3!Q -G7^&$5]
ML05)J<LW"W330FN.2(ADN\F[C$:HHEU9=K?.TIL&!<-(3BQERF_&T"3UBU6<
M& 7M*7UV0X233UIN.')#3MO/XL6W'A44WXUCSOR *Z>D_YN6KBZGXZ@Y=O.N
MI=D=*[;NLT -)C8/S$2F< ,JR%IP)W%4NT\8G>M;38>CFN*W:!S5SU((PE!,
MERP!_O@/=;=_TUSG/0J%/*@@XOPY?$'3MXD;_*/\_KU.Q_V>,'W,#G$CX:C)
M5RI;C)(NB")IMV8I2-H6ZW*DS$"Z-0C1 #%,PWL2?A1GMXJ09=T98*6-5N:K
M(+(<-'VO)Q.7VH+P!6G< 'SWA&.^^80C]'DY'R.FR:R16(R<*9"BK5RW%#1C
MFW492PU!.D)JV1A=7] 4RW,RX9_]N>[(9I!93YD^6)&THL9JV@RMGDC<UA6D
M;6/4/8CE*5M0EBS%AEP<3GMT23C;]&AHAO#07M8S>53L(J*5NUA-['&=GPAP
M89 WD P#E$$V%,BQ&J-ZY*\?0G&I@"<X_9+AP&G;K+>>Y -1BPP;Q%;3>ZCG
M$[D5]E#T;_K$?Q>&8M;B[%\?$]0Q3H9>:SVD%1&+@&J$5L-9U>^)8&:>;]0&
M2'=X(LT=1??#>2^8".\\P?2.!=,[,S"][P#FELO1BC;-94]L/K$179%#LU!0
MG@N3^_&T1&YEY\"CIMO7HE%:RPM.:=XTBLG5[A,;,/J,26!>-QGEYP*E(:B6
MS)+V'/ TM?Q:C.:K(C5"TZ .:,S]Z&^\J%S>&\3G JDVI!;1@O(< -4W_%IX
MINX@[)M:KLN#]AU#O@''4MEB '5!\IO,.S5+(=.V6/L6<P*5<&N*(ODH2328
M46*^/:.16$R3*9 BJERWE"ICFW7)2@PA<6SN6YJ_&.8<D1Z=SY<D^XXHUJ0U
MZ2SFK#*:@DTKLI2XZE[K8I>Y0M&V ?2&-,(!YIA,'\6%(\.^+K-69#%TYE"*
MN'V%I;A5-%J7M:TE*,\&0!LP).%&XH-+GA"23R2RI\E$>RZM%%L,WN&0"D"S
MTE(0CVBX+I#"V@EVO"$UA\2]>30?XGB)V(L U>UR/I@: QM@W=.?![+FME\-
MW'2(IOD=HF IKA\V'6\\PCS2+7,U$HOY- 7*S]ZENJ7\&=NLRUOB G0"'>^7
M\:^@_!M ;,1\^1.3X68^IKJHY;K%<&FC*+(*14NQTO=8FZG4#5*[!H]6]^M@
M)EI&AF<1#3*+P:H*5CYR[6HLQ:RRU=IKC\P4E&NSSR+>SQ&;"MI_9W3%9^+B
M8.&3C?$;<9/:8@:/B%F\3:&56DKD,1V?>*-"F4/J#IE]8X#VQ%4D\Z,'<?VX
M_@.9T=S760^E(5H1QY+(:A!-O9Z(8&8+B2\(XP;@NQ.KEU"N8#Y%_E03N%RW
M&#9M% 59H6@I7/H>ZT*5NX&TVT7IVMV.W!=;\O?7V5O9WK?_ U!+ P04
M" #'@YY5\F1J>X$$  "#)P  %0   &%Y='4M,C R,C$R,CA?<')E+GAM;-5:
M78_B-A1]K]3_X$V?0SZ8X4O#KAAVMD([[*"!55=]69G$@-7$CFPSP+^O'6)*
M0@*A:L/D!4)\?'WN.<;Q3?+P:1L&X TQCBGI&T[#-@ B'O4Q6?:--3<A]S V
M/GW\]9>'#Z;YX_'U&?C46X>(". Q! 7RP0:+%9C1*(($C!%C. C (\/^$@'@
MV T9M-$$IIG$>(1<]J$$Q,'<AG-H&2;Q*.D!Q[7<CN7:K@M:/?N^Y[; 9'Q
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M,9]PH-B]JJ/>/%[D[/++>^FMQ=Y'0%+/2*]@HOEA RS,'L(I2* K9EW-G\W
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M)R"[,/_WUF@FQMQ5F\*Z/79SV^O?QET"0+:N^^P" +X#KUZ9/;/5V5T8!!#
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M<HC91(57TYO-?1"&H6/4>?4!+S@"'?4JS"*CSX48B=E0^*S^EOBG!MO#;O#
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MT6D<V$OET=OQJN0 ?["J^DBCCO^'+FNGM9.#Z\%O:I8Q5WP!"/P!2WC(-#?
M4#>G&!>%"HR]X?X&?X9LZAXT3.R-<F\/%UEC&&:6@&?2+F,5ND*+%1DI%-=
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MTFLM!Y(A,/*:7G>NF'BAK?(<H ?HC+02:I]E$DAD#N) Q5@ P/1P,HQ38N9
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M."YX<V102P$"% ,4    " #'@YY5)1^P&G8%  !N/@  %0
M@ &@ P  87ET=2TR,#(R,3(R.%]L86(N>&UL4$L! A0#%     @ QX.>5?)D
M:GN!!   @R<  !4              ( !20D  &%Y='4M,C R,C$R,CA?<')E
M+GAM;%!+ 0(4 Q0    ( ,>#GE4BQ^7YJ!8  -2'   4              "
M ?T-  !A>71U+3(P,C(Q,C(X>#AK+FAT;5!+ 0(4 Q0    ( ,>#GE4:STB_
MC#0  ,17 0 8              "  =<D  !A>71U+3(P,C(Q,C(X>&5X.3ED
;,2YH=&U02P4&      4 !0!- 0  F5D

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
